Testing a prediction tool for lung and blood infections
Part of Infections, Lungs & breathing clinical trials.
This study is testing a new tool to predict how well people with pneumonia or sepsis will recover. If you have either infection and are 18 or older, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have either community-acquired pneumonia (symptoms started within 8 days) or sepsis.
- You are able to follow the study schedule and give your permission (informed consent).
- You do not have severe liver or kidney problems, are not pregnant or breastfeeding, and have not had an organ transplant.
- You do not have HIV, and have not had a recent untreated heart attack or stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This trial tests an emergency breathing-related approach for adults with a sudden, community-acquired respiratory infection. It may help doctors quickly sort out what’s going on and guide early care.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.